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Abstract
Purpose To study the levels of perceived threat, perceived
severity, perceived vulnerability, response efficacy, and self-
efficacy for severe acute respiratory syndrome (SARS) and
eight other diseases in five European and threeAsian countries.
Method A computer-assisted phone survey was conducted
among 3,436 respondents. The questionnaire focused on
perceived threat, vulnerability, severity, response efficacy,
and self-efficacy related to SARS and eight other diseases.
Results Perceived threat of SARS in case of an outbreak in
the country was higher than that of other diseases.
Perceived vulnerability of SARS was at an intermediate
level and perceived severity was high compared to other
diseases. Perceived threat for SARS varied between
countries in Europe and Asia with a higher perceived
severity of SARS in Europe and a higher perceived
vulnerability in Asia. Response efficacy and self-efficacy
for SARS were higher in Asia compared to Europe. In
multiple linear regression analyses, country was strongly
associated with perceived threat.
Conclusions The relatively high perceived threat for SARS
indicates that it is seen as a public health risk and offers a
basis for communication in case of an outbreak. The strong
association between perceived threat and country and
different regional patterns require further research.
Keywords Risk perception . SARS . Infectious diseases .
Efficacy beliefs . Risk communication .
International comparison
Introduction
Severe acute respiratory syndrome (SARS) and avian
influenza are two examples of recent emerging infectious
diseases that may cause severe threats to population health,
large economic losses, as well as fear and dread [1, 2]. The
behavior of the general population or specific risk groups
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can play an important role in both the spread and control of
infectious diseases. The SARS epidemic showed the impact
of worldwide travel on the rapid spread of an epidemic, as
well as the possible merits of strict hygiene and quarantine
measures in halting that epidemic [3]. In case of an
infectious disease pandemic, public health authorities will
be dependent on the willingness and ability of the general
public to adhere to recommendations regarding personal
hygiene, vaccination and/or prophylaxis, quarantine, travel
restrictions, or closing down of public buildings such as
schools [4, 5]. Compliance with recommended precaution-
ary behaviors is not self-evident [6]. Specific attention to
factors influencing behavioral change during outbreaks of
infectious diseases is, therefore, necessary.
One of the factors that may influence willingness and
motivation to adopt precautionary behaviors is risk percep-
tion [7–10], i.e., the perceived personal vulnerability or
likelihood of a disease or health threat. Perceived vulner-
ability, combined with perceived severity, can be regarded
as perceived threat. People are expected to have the highest
perceived threat of SARS if they think that an infection
with SARS is likely and will have serious health con-
sequences. However, risk perception is certainly not the
only determinant of protective behavior. Protection Moti-
vation Theory suggests that response efficacy (i.e., the
extent to which people believe that available protective
actions against SARS are effective) and self-efficacy (i.e.,
the extent to which people believe they have the ability to
engage in such protective actions) are two other key
predictors of protection motivation [8].
Risk perceptions are often biased. Unrealistic optimism
about risks is often observed toward familiar risks that are
perceived to be largely under volitional control. People
perceive their relative risk compared to others of the same
gender and age as lower. A pessimistic bias, i.e., percep-
tions of risk that are (much) higher than actual risk, is more
likely for new risks that are perceived as uncontrollable.
The latter might be the case with new emerging infectious
diseases, like SARS [9–12].
While in some fields, such as environmental risks, risk
perception has been studied intensively, not much is known
about risk perception of recently emerging infectious
diseases. Related to emerging infections diseases, first,
explorative and descriptive studies are needed to increase
our insights in perceived threat, risk perception, and
efficacy beliefs. Such studies can inform more focused
and theory-driven investigations. During and in the after-
math of SARS, several of such exploration studies have
been conducted, but these studies did not include interna-
tional comparisons across a range of different countries.
These studies showed that the risk of SARS was perceived
differently across the globe and was not directly linked to
the proximity of the outbreak. Risk perception of SARS in
some of the Asian countries was relatively low compared to
risk perception in the USA [13–15] but similar to levels
reported for The Netherlands [16]. One study focused on
differences in psychosocial factors predicting preventive
behavior in four affected regions [17]. Ji and colleagues
compared optimism related to SARS in China and Canada
and concluded that both groups demonstrated unrealistic
optimism, while at the same time they were overly pessimistic
about their own chances of getting infected [18]. A limited
number of studies have looked at risk perception of avian
influenza with different results varying from high perceived
risks to low risk perception [19–22]. A Dutch study showed
high levels of risk perception of avian influenza in case of an
outbreak and indicated that almost 40% of respondents had
taken some sort of precautionary measures [23].
There are few international comparative studies that
analyze differences in perceived threat, risk perception, and
efficacy beliefs between (infectious) diseases and condi-
tions and differences between countries [24–27]. It is
generally unknown whether risk perceptions of emerging
infectious diseases are perceived in similar ways across
countries. Because there was a large difference between
how SARS has affected Southeast Asia and Europe, one
might hypothesize that this would mean a higher risk
perception of SARS and possibly other infectious diseases
in countries in Southeast Asia. If international differences in
risk perceptions of SARS exist, the question is whether
such differences are specific for SARS, whether we see the
same for risk perception of avian influenza (as most cases
have also occurred in Southeast Asia), or whether they may
indicate a more general trend in risk perceptions.
The present study explored perceived threat, risk
perception, and efficacy beliefs related to SARS in random
samples of the population of eight countries in Europe and
Asia. To explore if country differences were specific for
SARS, perceived threat, risk perception, and efficacy
beliefs related to avian influenza and other (infectious)
diseases were also investigated. This study had the
following specific objectives:
– To study levels of perceived threat, vulnerability (or
risk perception), severity and comparative vulnerability
for SARS in Denmark, The Netherlands, Poland,
Spain, the UK, China, Hong Kong, and Singapore;
– To compare perceived severity, vulnerability, and threat
of SARS with other diseases and conditions, i.e., avian
influenza, common cold, diabetes, HIV, high blood
pressure, tuberculosis, food poisoning, and a heart
attack;
– To study differences and associations between these
factors across the eight countries and between Europe
and Asia.
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Because data collection for the present study took place
in the autumn of 2005, i.e., 2 years after the SARS
epidemic, it was not possible to collect information on
specific precautionary behaviors. Furthermore, specific
results on risk perception of avian influenza and related
efficacy beliefs have been reported elsewhere [23].
Methods
Procedure and Respondents
Data were collected using computer-assisted telephone
interviewing in the native languages by native speakers of
each country, coordinated by a Dutch company that
specializes in international telephone survey research, using
random digit dialing (RDD). For the Asian countries, the
Dutch company was assisted by an Asian agency. If
unanswered, numbers were tried again up to five times
and, when possible, call back appointments were made.
Interviews were conducted from 20 September to 22
November 2005 in eight different countries, five in Europe
representing regions in North, West, South, and East
Europe (Denmark, The Netherlands, Great Britain, Spain,
and Poland) and three regions in East Asia (Singapore,
province of Guangdong China, and Hong Kong). In China,
the survey was conducted in the province of Guangdong.
During the period of data collection, no cases of SARS
were reported. Respondents aged 18 to 75 years were
eligible for participation.
Questionnaire
The questionnaire was based on a previously developed
SARS risk perception questionnaire [16] and focused on
risk perception and severity of SARS, avian influenza, and
other (infectious) diseases, efficacy beliefs and use of
information sources and took, on average, 16 min to
complete. The questionnaire was first developed in English,
translated into Dutch, and subsequently pretested in Great
Britain and The Netherlands using cognitive interviewing.
Further translations were made into Danish, Spanish,
Polish, Mandarin, and Cantonese; all translations were
conducted by professional translators and checked by
native speakers, including members of the project team.
The questionnaire started with basic demographic ques-
tions, including urbanization and level of education (see
Table 1 for categories). Respondents were then presented
with the following diseases or conditions: diabetes, a
common cold, HIV, high blood pressure, SARS, tubercu-
losis, heart attack, flu from a new virus, and food
poisoning. These illnesses and conditions were included
as these are both infectious and noninfectious diseases,
some more common and familiar, and some with more
serious consequences, thus giving a range of options for
comparisons. For SARS and flu, the respondents first
received a brief explanation (for SARS, “SARS is a severe
acute breathing related illness caused by a previously
unknown virus”; for flu, “A new type of flu virus can arise
from avian flu, it causes serious illness and spreads easily in
the population”). Respondents were then asked about:
1. Severity (“How serious (on a scale from 1 to 10) would
it be for you if you got [disease] in the next year?”);
2. Vulnerability (“How likely do you think it is that you
will develop or contract a [disease] in the next year;
very unlikely (1) to very likely (5));
3. Comparative vulnerability (“How likely do you think it
is that you will develop or contract [disease] in the next
year compared to other [women/men] of your age in
[own country]; much less likely (1) to much more likely
(5)).
The questionnaire continued with two questions focusing
on knowledge of SARS (name symptoms, whether SARS is
a communicable disease).
For SARS, flu from a new virus, and common cold, the
following additional questions were included: response
efficacy [“To what extent do you think people can take
effective actions to prevent getting SARS/flu from a new
virus/common cold in case of an outbreak”; outbreak was
included for SARS and flu from a new virus; not at all (1)
to very much (4)]; self-efficacy [“How confident are you
that you can prevent getting SARS/flu from a new virus/
common cold in case of an outbreak”; not confident (1) to
very confident (4)]. The order of these three diseases was
chosen randomly by the computer. The questionnaire
continued with questions on use of sources of information
during the SARS outbreak, trust in these sources, and
preferences for ways of communication during future
outbreaks. Respondents where then presented with scenar-
ios and asked about possible preventive actions. Results of
this have been reported elsewhere [28]. The questionnaire
concluded with some general background questions on
perceived general health, perceived happiness, whether
respondent had been vaccinated against influenza, and about
employment status, education level, and religion. (The
questionnaire is available online at http://www2.eur.nl/fgg/
mgz/SARSControl/questionnaire_risk_perceptions_survey.
htm.)
Statistical Analysis
Respondents indicating they never heard about SARS
(1.3%) were excluded from the analyses. Furthermore,
“don’t know” answers on the questions about risk percep-
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tion were treated as missing values and, therefore, also
excluded from the analysis. On average, 4.4% of respond-
ents did not know how to rate SARS severity and 4.3%
could not rate their vulnerability to SARS.
For the different countries, mean scores and standard
deviations (SD) were calculated for severity, risk percep-
tion, perceived threat (see below), and comparative vulner-
ability of eight different diseases or conditions. In line with
the Protection Motivation Theory, one measure was defined
as “perceived threat”; it was constructed by multiplication
of the measures of perceived severity (scale 1–10) and
vulnerability (in case of an outbreak in the country for
SARS and flu from a new flu virus; scale 1–5). To make the
scores comparable, the severity score was first divided by
two. To normalize the skewed distribution of the new
variable, a square root transformation was performed that
resulted in a measure of perceived threat on a scale from 1
(low) to 5 (high). A SARS knowledge score (scale 0–2)
was calculated based on whether the respondent could
name a symptom of SARS and whether the respondent
knew SARS was a communicable disease. Differences in
background characteristics (gender, age group, area, and
level of education) and risk perceptions between the
samples in Europe and Asia were explored with chi-square
tests or (paired) Student’s t tests, of which the p value and
the effect size r are reported. An r below 0.30 indicates low
effect size, 0.30–0.50 indicates medium effect sizes, and
higher than 0.50 indicates large effect size.
To test for important correlates of SARS-related risk
perceptions, four multiple linear hierarchical regression
models were applied with perceived severity, vulnerability,
threat, and comparative vulnerability as dependent varia-
bles. The independent variables were included in blocks
with country (dummy coded) in the first block, sex, age,
highest education, and urbanization in the second block,
and the amount of information during the SARS outbreak
and the SARS knowledge score in the last block. As we
did not want to choose one country as a reference group,
we ran the models by leaving out the intercept. In doing
so, the regression coefficients for the countries do not
represent the difference in mean compared to the reference
group but the actual (corrected) mean value of the
respective dependent variable. The R2, a measure of the
proportion of variance in the dependent variable that is
explained by the independent variables in the model, is
given for each hierarchical step in the models. The models
were applied to the total population and the model for
perceived threat was also applied to the separate countries.
Results
Response and General Characteristics
In the European countries, 16% of the numbers created by
RDD were nonexistent and 26% of the numbers could not
Table 1 Participation rates and distribution of general characteristics in the study population
DNK
(%)
POL
(%)
NLD
(%)
GBR
(%)
ESP
(%)
CHN
(%)
HKG
(%)
SGP
(%)
Europe
(%)
Asia
(%)
Total
(%)
Total n 463 488 400 401 425 404 396 426 2,177 1,226 3,403
Total % 14 14 12 12 12 12 12 13 64 36 100
Participation rate 58 81 44 21 34 – – – 40 13
Gender
Male 40 39 42 41 41 47 44 43 40 45 42
Female 60 61 58 59 59 53 56 57 60 55 58
Age group
18–30 13 18 10 13 17 43 27 35 14 35 22
31–45 31 31 31 35 34 34 35 31 32 33 33
44–60 36 32 37 31 32 19 27 20 33 22 29
61–75 20 19 24 21 17 4 12 14 20 10 16
Area
City 26 21 9 20 45 86 90 81 24 86 46
Town 38 25 37 45 42 9 4 16 37 10 27
Village/countryside 37 54 55 36 13 4 6 2 39 4 26
Education
Primary or lower 17 8 5 2 22 4 13 3 11 7 9
Low 31 22 28 20 9 19 20 11 22 16 20
Intermediate 38 43 35 35 31 35 32 38 37 35 36
High 13 28 32 43 38 42 35 48 30 42 34
DNK Denmark, POL Poland, NLD The Netherlands, ESP Spain, CHN China, HKG Hong Kong, SGP Singapore
Int. J. Behav. Med. (2009) 16:30–40 33
be reached after five times. Of the people eligible for
participation, 40.2% completed the interview and 59.8%
refused. Participation rates varied from 21.3% in the UK to
81.1% in Poland (see Table 1). For the interviews
conducted by the Asian agency, no response rates are
available. In total, 3,436 respondents were interviewed.
Data on background variables in the different participat-
ing countries are provided in Table 1. Most respondents in
all countries were female (58% in the total group).
European respondents were significantly older than Asian
respondents (p<0.001, r=0.27). Substantially more
respondents in Asia lived in a city, as both Hong Kong
and Singapore were included (p<0.001, r=0.56). Asian
respondents were higher educated than European respond-
ents (p<0.001, r=0.014).
Risk Perception and Severity of SARS and Other Diseases
SARS was rated as the third most severe problem among
the diseases and conditions included, HIV as the most
serious problem and common cold as the least serious (see
Table 2). Compared to flu from a new flu virus, SARS was
rated more serious in all countries (overall=8.3 versus 7.0
(scale 1–10), p<0.001, r=0.47; country-specific test results
not shown). Perceived vulnerability, risk perception, for
common cold was the highest, 3.8, and for HIV the lowest,
1.4 (scale 1–5). For SARS, the risk perception levels
differed in case of an outbreak in or outside the country. It
was among the highest with 2.7 in case of an outbreak in
the country, while in case of an outbreak outside the
country it was 2.1 (p<0.001, r=0.44). The vulnerability for
an outbreak of flu from a new flu virus was higher than for
SARS both in case of outbreak inside the country (3.1
versus 2.7, p<0.001, r=0.31) and outside the country (2.9
versus 2.1, p<0.001, r=0.48). This finding was true for all
countries (separate test results not shown).
Perceived threat of SARS in case of an outbreak in the
country was among the highest of the diseases with a mean
score of 3.2 (scale 1–5); perceived threat of HIV (2.4) and a
common cold (2.1) were the lowest. Perceived threat of
SARS and flu from a new flu virus in case of an outbreak
were similar in most countries, but in Denmark, China, and
Hong Kong, SARS was perceived more threatening than flu
from a new flu virus (p<0.001, r=0.23; p<0.001, r=0.25;
and p=0.004, r=0.15, respectively).
The level of perceived threat varied across countries.
Perceived threat of SARS was the highest in Poland and the
lowest in Singapore. In Fig. 1, the results of perceived
threat of SARS, flu from a new virus, high blood pressure,
and diabetes are presented. Although levels of perceived
threat varied between countries, the pattern of perceived
threat differences between the different diseases and
conditions was the same in all countries with perceived
threat of SARS and avian flu being the highest and diabetes
the lowest.
The comparative vulnerability of SARS in case of an
outbreak outside the country was 2.6 (scale 1–5), indicating
that that people thought it slightly less likely that they
would contract SARS compared to the average other
(Table 2). The much lower value for HIV (1.6, p<0.001,
r=0.65) indicates that participants, on average, thought it
much less likely to contact HIV compared to other people
of the same age and gender.
Comparison Europe–Asia
SARS was perceived as a more severe problem in Europe,
8.42, compared to Asia, 8.02 (on a scale of 1–10 [p<
0.00005, r=0.09])), while Asia perceived a higher vulner-
ability, 2.54 (Europe, 1.86; p<0.00005, r=0.29; see
Table 3). For flu from a new flu virus, perceived severity
was higher in Europe, 7.06 to 6.74 in Asia (p<0.0005, r=
0.06) as was perceived vulnerability, 3.16 to 2.97 (p<
0.00005, r=0.08). In comparing Europe to Asia, there is not
one pattern for all diseases, some are perceived more severe
in Europe (heart attack, HIV), others in Asia (food
poisoning, common cold) nor is there for perceived
vulnerability.
Knowledge and Efficacy Beliefs
Of the respondents in the Asian countries, more than 80%
could name symptoms of SARS; this percentage was just over
40% in European countries. The proportion who knew SARS
was a communicable disease varied between 62% in Spain
and 88% in Denmark. The mean knowledge score was 1.2
(range 0–2) in Europe and 1.7 in Asia (p<0.001, r=0.69).
Self-efficacy was lower than response efficacy for both
SARS and a common cold in all countries, but the difference
was larger for SARS. Both response efficacy and self-
efficacy for SARS were higher in the Asian countries
compared to the European countries (p<0.001, r=0.28 and
p<0.001, r=0.40, respectively; see Fig. 2).
Linear Regression Model
The regression models for perceived severity, vulnerability,
threat, and comparative vulnerability for all countries
combined are presented in Table 4. Country was signifi-
cantly associated with perceived threat, vulnerability,
severity, and comparative vulnerability. Besides country, a
higher perceived severity of SARS was significantly
associated with female gender, lower level of education,
and a higher SARS knowledge score. A higher perceived
vulnerability for SARS was significantly associated with
lower level of education.
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All the variables that were significantly associated with
severity and vulnerability were also significantly associated
with perceived threat. Comparative vulnerability was signif-
icantly associated with gender and amount of information.
Comparative vulnerability in women was lower than in men
and lower in respondents that received more information
about SARS. The models for each outcome variable
explained less than 10% of the variance (Table 5). The
proportion of the variance explained by country was higher
than that for the other potential correlates in the models.
Analysis per country (Table 6) showed that perceived
threat of SARS was higher in respondents with lower levels
of education in Poland, Great Britain, and Spain, while it
was higher among the higher educated in Singapore.
Singapore was the only country where age was indepen-
dently associated with perceived threat. Level of urbaniza-
tion was a significant correlate in Poland only with living in
less urban areas associated with a lower threat. In The
Netherlands and Denmark, perceived threat was higher in
respondents who received higher amounts of information
about SARS, and in Great Britain, it was higher in
respondents with a higher knowledge score. The model
for the total population explained 7.5% of variance of
which 5.9% was accounted for in a model with only the
country variable (Table 5). In the separate models by
country, the explained variance was less than 5% in all
countries.
Discussion
The present study shows that perceived threat of SARS in
case of an outbreak in the country was higher than that of
other diseases and conditions included in this study.
Perceived vulnerability of SARS was at an intermediate
level compared to other diseases while perceived severity
was high. Perceived threat for SARS varied between
countries in Europe and Asia with perceived severity higher
in Europe and perceived vulnerability higher in Asia.
Perceptions of vulnerability compared to other people for
SARS was relatively small and comparable to other
diseases. Response efficacy and self-efficacy for SARS
were higher in Asia compared to Europe.
Our study has several limitations, especially related to
the means of data collection. Firstly, the response rate
varied substantially between countries from 21.3% to
81.1% with low response rates in the participating Asian
Table 2 Mean scores and standard deviations (SD) of severity, vulnerability, and perceived threat of eight different diseases and conditions,
N=3,436
Disease Severity
(scale 1–10)
Vulnerability
(scale 1–5)
Perceived threata
(scale 1–5)
Comparative vulnerability
(scale 1–5)
Mean SD Mean SD Mean SD Mean SD
SARS. outbreak in countryb 8.3 2.1 2.7 1.2 3.2 0.9 2.6 1.0
Heart attack 8.4 2.1 2.5 1.2 3.1 0.9 2.5 1.1
Flu from new virus. outbreak in countryb 6.9 2.5 3.1 1.2 3.1 0.9 2.8 1.0
Flu from a new flu virusb 6.9 2.5 2.9 1.2 3.0 0.9 2.7 1.0
SARS. outbreak outside countryb 8.3 2.1 2.1 1.1 2.8 0.9 2.2 1.0
High blood pressure 6.4 2.2 2.4 1.2 2.7 0.9 2.4 1.1
Tuberculosis 7.3 2.3 2.0 1.0 2.6 0.8 2.1 0.9
Food poisoning 5.6 2.5 2.6 1.2 2.6 0.9 2.4 1.0
Diabetes 6.8 2.5 2.0 1.1 2.5 0.9 2.2 1.0
HIV 9.1 2.1 1.4 0.8 2.4 0.7 1.6 0.8
Common cold 2.8 2.1 3.8 1.2 2.1 0.9 3.0 1.0
a Perceived threat is the square root of the multiplication of severity/2 and vulnerability. Diseases are ranked by perceived threat score
b Severity of SARS and flu from a new virus was asked in general. The mean score is given in the table for both situations (outbreak in or outside country)
* difference in mean perceived threat between SARS and flu is statistically significant
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Fig. 1 Mean perceived threat of SARS and flu from a new flu virus in
case of an outbreak, high blood pressure and diabetes by country. The
asterisk indicates that the difference in mean perceived threat between
SARS and flu is statistically significant
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countries in particular. This may have led to nonrepresen-
tative samples, and the differences in response rates may
partly explain the reported differences in risk perceptions
and other variables. These differences in response rates and
the low rates in some of the participating countries limit the
generalizability of our data, and the results should,
therefore, be interpreted with caution.
Secondly, because of the lack of an existing validated
questionnaire for perceived threat and risk perception of
infectious diseases suitable for telephone administration in
large samples, the questionnaire was specifically devel-
oped for the project reported in this paper based upon an
earlier questionnaire used during the SARS outbreak [16].
Our study design, aiming to include a large number of
respondents from a range of different countries and
regions, using telephone surveying as the means of data
collection, combined with the financial and time pressure
restraints, enabled the inclusion of only a limited number
of items per construct. This may have reduced the
reliability of our measures, especially toward possible
underlying cultural differences in constructs. Furthermore,
extensive pretesting of the survey questionnaire with
cognitive interviewing was restricted to two European
countries. We, therefore, do not know whether all concepts
used were understood in the same way in all participating
countries. On the other hand, we did contextualize our risk
perception questions by including a setting (in case of an
outbreak), time frame (next 12 months), and focusing on
the risk of the individual (instead of population)—all
issues known to be important for measuring risk percep-
Table 3 Mean scores of severity and vulnerability for different diseases and conditions compared for Europe and Asia
Disease Severity (scale 1–10) Vulnerability (scale 1–5)
Europe Asia Difference T valuea Europe Asia Difference T valuea
SARS, outbreak outside countryb 8.42 8.02 0.40 4.8*** 1.86 2.54 −0.68 4.8***
SARS, outbreak in countryb 8.42 8.02 0.40 4.8*** 2.69 2.70 −0.01 −0.3
Flu from a new flu virusb 7.06 6.74 0.32 3.6** 2.89 2.82 0.07 1.5
Flu from new virus, outbreak in countryb 7.06 6.74 0.32 3.6** 3.16 2.97 0.19 4.5***
Heart attack 8.87 7.45 1.42 18.2*** 2.53 2.36 0.17 3.8**
High blood pressure 6.41 6.48 −0.07 −0.9 2.45 2.36 0.10 2.1
Tuberculosis 7.60 6.66 0.94 10.5*** 1.88 2.18 −0.30 −7.7***
Food poisoning 5.46 5.80 −0.34 −3.7** 2.56 2.71 −0.14 −3.4*
Diabetes 6.88 6.59 0.28 3.1* 1.91 2.16 −0.24 −6.1***
HIV 9.41 8.48 0.93 10.9*** 1.36 1.46 −0.09 −3.3*
Common cold 2.45 3.52 −1.07 −13.9*** 3.86 3.58 0.28 6.9***
*p<0.0025, ** p<0.0005, *** p<0.00005
a To adjust for multiple testing, the significance level was divided by the number of comparisons (20) using the Bonferroni adjustment
b Severity of SARS and flu from a new virus was asked in general. The mean score is given in the table for both situations (outbreak in or outside country)
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Fig. 2 Mean response efficacy and self-efficacy for SARS in case of an outbreak and a common cold by country
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tions, although not always included in studies on risk
perceptions [7].
Data collection took place in autumn 2005, 2 years after
the end of the SARS epidemic. This may have influenced
the recollection of knowledge and use of information
sources during the SARS epidemic. However, the study
consortium responsible for the present study also conducted
qualitative explorations of risk perceptions, efficacy beliefs,
and precautionary actions among Chinese populations in
the UK and The Netherlands, showing similar results (Jiang
et al., submitted for publication).
The present study also has its strengths. It is among the
first large-scale comparative studies into perceived threat
and risk perception of emerging infectious diseases, and in
fact, unique in the number of countries represented.
Perceived threat for SARS, as well as avian influenza,
were among the highest and at the same level as for, for
example, a heart attack. This indicates that these potential
problems were taken very seriously by the general public.
Because few comparative studies into perceived threat of
SARS and other newly emerging infectious diseases have
been conducted, it is difficult to interpret the differences
between countries and continents. Comparing our results
with data from several earlier studies on risk perception of
SARS in the USA, Canada, The Netherlands, Singapore
and Hong Kong has its limitations, as these studies were
done in 2003 during the SARS epidemic, whereas in our
study, we asked respondents to envisage a new outbreak
[13–16]. For example, in 2003, risk perception of SARS in
some of the Asian countries was relatively low compared to
risk perception in the USA. Ji et al., in their study on
optimism across cultures, have pointed out that unrealistic
optimism concerning SARS was higher among Chinese
than among Canadians [18]. They interpreted this being in
line with the Chinese and East Asians in general holding a
cyclical perception of events, so that a negative event may
be seen as antecedent to a positive outcome.
The higher level of severity of some diseases in Europe
(SARS, flu from a new virus, HIV, tuberculosis) may
indicate that more unfamiliar diseases are perceived more
severe. The higher perceived vulnerability for some
diseases (SARS, tuberculosis, HIV) in Asia may be based
Table 4 Correlates of perceived SARS severity, vulnerability, perceived threat and comparative vulnerability; unstandardized regression
coefficients (B) and p values derived from linear regression analyses (n=3064)
Seriousness Vulnerability Threat Vulnerability compared to other people
B p B p B p B p
Countrya <0.001 <0.001 <0.001 <0.001
Denmark 8.40 2.32 2.95 −0.76
Poland 8.16 3.23 3.50 −0.25
The Netherlands 8.23 2.96 3.37 −0.30
Great Britain 8.05 2.68 3.11 −0.55
Spain 7.94 2.83 3.23 −0.29
China 8.09 2.70 3.14 −0.78
Hong Kong 8.01 3.01 3.34 −0.47
Singapore 6.83 2.57 2.73 −0.97
Sex (male is the reference) 0.57 0.000 0.07 0.090 0.17 0.000 0.08 0.014
Age 0.00 0.237 0.00 0.875 0.00 0.303 0.00 0.300
Highest education −0.14 0.001 −0.08 0.001 −0.07 0.000 −0.01 0.669
Urbanization −0.07 0.118 −0.02 0.365 −0.04 0.059 −0.02 0.261
Amount of info during SARS outbreak 0.05 0.155 0.03 0.188 0.03 0.090 0.04 0.019
SARS knowledge score 0.16 0.010 0.05 0.170 0.07 0.016 0.04 0.134
a The p value for country stands for the overall significance of the differences between countries
Table 5 R2 of the different steps in the linear regression models and significance in F change
Seriousness Vulnerability Threat Comparative vulnerability
R2 p R2 p R2 p R2 p
R2 step 1 0.041 0.000 0.053 0.000 0.059 0.000 0.062 0.000
R2 step 2 0.064 0.000 0.057 0.008 0.072 0.000 0.064 0.051
R2 step 3 (full model) 0.067 0.004 0.058 0.095 0.075 0.004 0.067 0.007
Adjusted R2 full model 0.063 0.054 0.072 0.063
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upon the fact that these are indeed more prevalent in these
regions.
The observation that, compared to Europe, efficacy
beliefs for SARS were more positive in Asia and that
people felt more able to control SARS, may be explained
in the same way. Alternatively, it may also be that the
more direct and closer experience with the disease in Asia
and the experience of outliving and overcoming the
outbreak have increased self-efficacy and response effica-
cy beliefs in Asia. Preventive measures in Asia were also
more visible and might have been more reassuring to the
public [2]. Also, efficacy beliefs related to a common cold
and flu from a new virus were higher in Asian countries
where the latter may be explained by the fact that, despite
the first cases of avian influenza among humans in Asia
already reported in 2003, this has not resulted in a larger
outbreak [22].
The lower level of risk perception in Denmark may
reflect part of a Scandinavian tendency to perceive risks
lower than in other countries [29]. This result is also in line
with a lower risk perception of SARS among Finns
compared to Dutch [24, 30]. One of the explanations for
this tendency is that the media in Scandinavia appear to
report more about risks abroad with less attention to risk
inside the country [29]. However, we need to interpret the
differences between countries with care because cognitive
constructs such as risk perceptions are not necessarily
interpreted in the same way in different cultures [31].
Indeed, the data of our study on comparison of risk
perceptions for various diseases show that the relative risk
perceptions for these diseases, i.e., the order of levels of
risk perceptions, are rather consistent across countries. This
may indicate that differences between countries in absolute
risk perception levels for specific diseases or conditions
may reflect cultural differences in the way survey questions
are answered rather than real differences in risk perceptions.
Voeten et al. [32], in their study on risk perception and
efficacy beliefs among Chinese communities in the UK and
The Netherlands, have shown that efficacy beliefs of
Chinese living in the UK and The Netherlands were
comparable to those of native UK and Dutch respondents.
This may indicate that country of residence, perhaps
because of country-specific public health systems and
media coverage, may be more important than ethnicity or
country and culture of origin. Because country appears to
be a relevant correlate of SARS-related risk perceptions in
the multivariate analyses, further research is needed to
explain these country differences.
The results on comparative vulnerability indicate that
envisioning an outbreak might make a difference; when
respondents were asked to compare their personal risk to
that of comparable others, the optimistic bias was lower in
case of an outbreak. Such a situation is characterized byTa
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less control, which is associated with less optimism [33,
34]. The notion that, for an outbreak, risks were perceived
to be more evenly distributed, and thus they seemed to be
less prone to an optimistic bias, may offer starting points
for public interventions. Such interventions should certainly
also focus on increasing self-efficacy, especially in the
European countries, because low self-efficacy may lead to
lack of protection motivation.
Perceived threat of SARS and flu from a new flu virus in
case of an outbreak was similar in most countries. However,
the level of severity for SARS was higher than for flu from a
new virus, while vulnerability for flu from a new virus was
higher than for SARS in all countries. One explanation might
be that SARS is a more unfamiliar disease for most people
compared to flu. It indicates that people do perceive various
aspects of risk perceptions differently for different emerging
infectious diseases and that risk communication should thus
be disease- and perception-specific.
Perceived threat for emerging infectious diseases such as
SARS and avian influenza were amongst the highest rated
in the present study, especially in case of an outbreak. From
a public health perspective, this offers a good starting point
for risk communication and precautionary actions. It also
asks for realistic risk communications to put the risks for
SARS and other emerging infectious diseases into the
perspective of global health risks to prevent fuelling
unnecessary panic [35].
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